Sai Parenteral's Ltd.

•

saiparenterals.comBSE: 544742NSE: SAIPARENT

Market Cap₹ 2,305 Cr.

Current Price

High / Low₹ 706 / 400

Stock P/E139.7

Book Value₹ 177

Price to Book2.96

Dividend Yield0.00 %

ROCE6.1 %

ROE4.9 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.60x)

CONS

A large part of profit comes from other income (83.3% of PBT)
Interest coverage is weak at 1.6x - earnings barely cover interest
Total debt has risen sharply - up 240.0% year on year
Equity base is being diluted - shares outstanding up 208.9%
Working capital days have increased from 84 to 239 days
Operating margins have contracted to 9.8% from 19.4%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1864.00	36.98	447236.04	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9405.00	85.36	249673.20	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4928.40	85.95	187460.49	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1118.00	24.71	111520.93	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1380.00	33.08	111484.47	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1936.00	95.67	104604.45	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1669.00	25.87	96030.57	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	DRREDDY	1140.80	29.55	95220.28	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LUPIN	2075.00	17.16	94882.67	0.87	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2246.00	45.42	92769.93	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2417.00	37.94	68213.70	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SAIPARENT	521.75	139.67	2305.05	0.00	79.23	—	1786.72	—	6.10	13.16

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2025	Mar 2026	Jun 2026
	33	198	179
	33	172	173
Operating Profit	1	26	6
OPM %	2.49%	13.18%	3.39%
	1	3	4
Interest	2	8	9
Depreciation	1	8	8
Profit before Tax	2	12	10
Tax %	29.43%	-6.13%	19.07%
Net Profit	1	13	8
	0.11	4.02	1.79

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	97	154	163	381
	78	122	124	344
Operating Profit	19	32	39	37
OPM %	19.15%	20.54%	24.15%	9.80%
	0	2	1	10
Interest	6	11	12	19
Depreciation	6	9	8	17
Profit before Tax	7	13	20	12
Tax %	39.64%	32.97%	27.54%	-19.54%
Net Profit	4	8	14	14
EPS	6.16	6.71	5.33	3.74
Dividend Payout %	0.00%	0.00%	0.00%	0.00%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 58%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 56%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 13%
Last Year:: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7	13	13	22
Minority Interest	0	2	2	4
	24	61	80	469
	69	110	87	579
Trade Payables	22	53	58	149
	12	28	31	194
Total Liabilities	134	267	272	1,416
	44	70	53	364
Capital Work in Progress	2	0	0	212
	13	37	51	172
	0	127	127	181
Cash & Bank	0	4	2	417
	75	29	38	70
Total Assets	134	267	272	1,416

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-10	-30	33	93
Cash from Investing	-19	-46	0	-274
Cash from Financing	24	79	-36	596
	-8	2	-2	415

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Mar 2026	Jun 2026
	51.16	51.16
	5.73	4.03
	12.86	8.52
Government	0.00	0.00
	30.26	36.29

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10

Shareholders meeting

2026-09-10 - Sai Parenterals Limited has informed the Exchange about Shareholders meeting

2026-08-25

Press Release

2026-08-25 - Sai Parenterals Limited has informed the Exchange regarding a press release dated August 25, 2026, titled "Announcement under Regulation 30 (LODR)".

2026-08-25

Bagging/Receiving of orders/contracts

2026-08-25 - Sai Parenterals Limited has informed the Exchange about Bagging/Receiving of orders/contracts

2026-08-25

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-25 - Sai Parenterals Limited has informed the Exchange about Schedule of meet

2026-08-20

Copy of Newspaper Publication

2026-08-20 - Intimation-Newspaper Publication of Notice of 25" Annual General Meeting of the Company for the financial year 2025-26.

2026-08-20

Copy of Newspaper Publication

2026-08-20 - Submission of Newspaper Publication(s) in PAS-1 for change and variation in the objects of utilization of the Initial Public Offering ( IPO ) proceeds

2026-08-19

General Updates

2026-08-19 - Sai Parenterals Limited has informed the Exchange about Intimation of Book closure and cutoff date for the 25th Annual General Meeting

2026-08-19

Shareholders meeting

2026-08-19 - Sai Parenterals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 10, 2026

2026-08-18

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-18 - Sai Parenterals Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for SAIPARENT

Loading news…

🤖

AI Stock Analyst

Sai Parenteral's Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1864.00

36.98

447236.04

0.86

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9405.00

85.36

249673.20

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4928.40

85.95

187460.49

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1118.00

24.71

111520.93

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1380.00

33.08

111484.47

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1936.00

95.67

104604.45

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

AUROPHARMA

1669.00

25.87

96030.57

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

DRREDDY

1140.80

29.55

95220.28

0.70

435.60

-69.10

8099.80

-5.21

13.75

10.63

LUPIN

2075.00

17.16

94882.67

0.87

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2246.00

45.42

92769.93

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2417.00

37.94

68213.70

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SAIPARENT

521.75

139.67

2305.05

0.00

79.23

—

1786.72

—

6.10

13.16

Jun 2025

Mar 2026

Jun 2026

198

179

172

173

Operating Profit

OPM %

2.49%

13.18%

3.39%

Interest

Depreciation

Profit before Tax

Tax %

29.43%

-6.13%

19.07%

Net Profit

0.11

4.02

1.79

Mar 2023

Mar 2024

Mar 2025

Mar 2026

154

163

381

122

124

344

Operating Profit

OPM %

19.15%

20.54%

24.15%

9.80%

Interest

Depreciation

Profit before Tax

Tax %

39.64%

32.97%

27.54%

-19.54%

Net Profit

EPS

6.16

6.71

5.33

3.74

Dividend Payout %

0.00%

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

Minority Interest

469

110

579

Trade Payables

149

194

Total Liabilities

134

267

272

1,416

364

Capital Work in Progress

212

172

127

181

Cash & Bank

417

Total Assets

134

267

272

1,416

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-10

-30

Cash from Investing

-19

-46

-274

Cash from Financing

-36

596

-8

-2

415

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2026

51.16

5.73

4.03

12.86

8.52

Government

0.00

30.26

36.29

Sai Parenteral's Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Sai Parenteral's Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI